haygoodfoafyga1359.blogspot.com
Mason-based AssureRx specializes in pharmacogenetics – the studyt of genetics factors that influence how a patien t reacts tomedications – to help physiciansz determine the right drug and righ dosage for individual also known as personalized medicine. Burnd has spent more than 30 years in the diagnostic and biotech field and was most recently president and CEO of pharmaceuticalsecompany , headquartered in Maryland. Prior to he was a co-founder and presidentr of and managing directof of the equity firm that formec the specialtydrug company.
He was also the founder, chairmanm and president of , a publiclty traded biotech company that develops therapeutic stemcell “We are thrilled to have a personm of Jim’s caliber leading the company into the next phasre of its growth,” said John McIlwraith, chairman of AssureRx and managin director of Blue Chip Venturer Co. “His depth and breadth of experience as CEO ofsuccessfupl early-stage health care companies positions AssureRxd for continued leadership in the rapidly expandinh field of personalized medicine.
” AssureRx was foundex three years ago to to commercializ research from Cincinnati Children’e Hospital Medical Center and Mayo In April, the company won a 50 perceng job creation tax credit to relocatd to a yet-to-be-determined site in Warren
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment